Telomerase Inhibition Targets Clonogenic Multiple Myeloma Cells through Telomere Length-Dependent and Independent Mechanisms

Sarah K. Brennan, Qiuju Wang, Robert Tressler et al. · 2010

Read Telomerase Inhibition Targets Clonogenic Multiple Myeloma Cells through Telomere Length-Dependent and Independent Mechanisms by Sarah K. Brennan, Qiuju Wang, Robert Tressler et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012487.txt.

Description

Sarah Brennan, Qiuju Wang, Robert Tressler and colleagues blocked telomerase in multiple myeloma, in a 2010 PLOS ONE paper. Most myeloma tumor cells cannot sustain endless growth; a rarer clonogenic pool reseeds the cancer. Telomerase, the enzyme that maintains chromosome ends, keeps such stem-like cells going in many cancers and is a prized drug target.

Telomerase inhibition hit the clonogenic myeloma cells through both telomere shortening and a second, independent mechanism. Hitting the reseeding pool is what a lasting therapy must do, since killing only the bulk invites relapse. The dual mechanism strengthens the case for telomerase drugs in this blood cancer.

Catalog record

CREATORSarah K. Brennan, Qiuju Wang, Robert Tressler et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012487

Browse the full library · About the Tower of Babel